Global Bacterial Disease Diagnostics Market 2024-2028
The bacterial disease diagnostics market is forecasted to grow by USD 4341.7 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the bacterial disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by integration of digital health in rapid diagnostics for bacterial disease, high prevalence of infectious diseases, and growing geriatric population.
Technavio's bacterial disease diagnostics market is segmented as below:
By Product
By End-user
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing demand for portable analytical instruments as one of the prime reasons driving the bacterial disease diagnostics market growth during the next few years. Also, growing number of merger and acquisition (m and a) activities and growing healthcare expenditure will lead to sizable demand in the market.
The report on the bacterial disease diagnostics market covers the following areas:
- Bacterial disease diagnostics market sizing
- Bacterial disease diagnostics market forecast
- Bacterial disease diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bacterial disease diagnostics market vendors that include Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., QIAGEN NV, Quest Diagnostics Inc., Revvity Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc.. Also, the bacterial disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.